{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"salla-disease","columns":[{"gene":"","key":"population-a7e411db59480682eb71","label":"Salla disease","mondoId":"MONDO:0011449","onsetQualifier":null,"originColumnKey":"MONDO:0011449/OMIM:604369","originalViews":[{"key":"MONDO:0011449/OMIM:604369","label":"Salla disease","scopeLabel":"OMIM:604369","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["17159327a4b9abbd087a654ab00c56104661dfce21cd45487df790ac849815f0","365af1a2ce4194b46d1a946f0fc77b315be56e0186eed2cea4ff42ba26d33d20","385de33c23ea72889bc0388bf8328c31988a7de57b43ee31cb51b2d844dc6556","41b7eb0f152567c1681ef77ce0e7e49747f072e7c00bb72364d3d9a062a09760","4303c09d7ef57d030065e5ed902fa21041f4f2d287dd4b066b00f6aabf8e4189","59f7e34e96c82d43f26169349b49184b8857bc58050e20ebd943ef79e5ba2290","86e9d5f297ee594df7f45baf174d037cd7677cb61bba268229c5ce004a90d83d","8b615393af23131f751a0873c8b45ece50dea4a8fa14aea6d0baf045ba5fcf39","93788962841d1313db9553fc51fe107348c02634fde482bdd5ebc58aee7b30e1","9465ed937a06cef2d8f0d52ef53ffd8d1337636dab1c3a9bd9ba449793bf2532","a1ae4e67d24e9a9fbb63cd01d8a92075ef6bacaacf5fbed8af8fd1699d0242f7","a4cc05008e1da088a62ea2f6983b07cdbd6bde3a7c5faa65ee8d42ada26679f3","b18c2685f9a9f3ae557be7545217dd4c8f0ce1bf010248374b903a933aee0deb","ba65364c82298a91287bb76ddeda9edd131bd34d632a24866f5c0ca7305dcfaf","bec4cc46b3180f7e7ea2b27f947147b455ed1bb0fd5cb26071f078001f7b3294","c5198ab12085969bbfc48144d62c77730a26d6e1d61ace4f0c2a96072388ffd9","d115f486f45d2b50c888e31dcc3befd9eb379ada3fc294dcf4da5c7bdd9f9ffe"],"recordQualifiers":{},"scopeLabel":"OMIM:604369","sourceIds":["OMIM:604369"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-a7e411db59480682eb71"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001939","HP:0001251","HP:0002305","HP:0000750","HP:0001260","HP:0000577","HP:0001290"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":17,"sourceGroups":{"omim":17}},"features":[{"hpoId":"HP:0001939","label":"Abnormality of metabolism/homeostasis","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0002305","label":"Athetosis","primary":true},{"hpoId":"HP:0000750","label":"Delayed speech and language development","primary":true},{"hpoId":"HP:0001260","label":"Dysarthria","primary":true},{"hpoId":"HP:0000577","label":"Exotropia","primary":true},{"hpoId":"HP:0001290","label":"Generalized hypotonia","primary":true},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0001510","label":"Growth delay","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0002540","label":"Inability to walk","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0000639","label":"Nystagmus","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false},{"hpoId":"HP:0002684","label":"Thickened calvaria","primary":false},{"hpoId":"HP:0001922","label":"Vacuolated lymphocytes","primary":false}],"ledeHtml":"Salla disease is the mildest form of the free sialic acid storage disorders, which primarily affect the nervous system. Infants with Salla disease typically begin to experience poor muscle tone (hypotonia) during the first year of life,followed by slowly progressive neurological problems. Signs and symptoms include intellectual disability and developmental delay; seizures ; ataxia ; muscle spasticity; and involuntary slow movements of the limbs (athetosis). About one-third of affected children learn to walk. It is caused by mutations in the SLC17A5 gene and is inherited in an autosomal recessive manner. Treatment is generally symptomatic and supportive.","mondoId":"MONDO:0011449","node":{"canonicalSlug":"salla-disease","comparisons":[{"documentSha256":"4585f679bbc3effe27809fcb72a878dd5b09e07f428bbffca19b2b766f3d4e3a","key":"legacy-salla-disease","kind":"legacy","label":"Salla disease","memberIds":["MONDO:0011449"],"mondoId":"MONDO:0011449","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/salla-disease.4585f679bbc3effe27809fcb72a878dd5b09e07f428bbffca19b2b766f3d4e3a.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"Salla disease","paragraphs":["Salla disease is the mildest form of the free sialic acid storage disorders, which primarily affect the nervous system. Infants with Salla disease typically begin to experience poor muscle tone (hypotonia) during the first year of life,followed by slowly progressive neurological problems. Signs and symptoms include intellectual disability and developmental delay; seizures ; ataxia ; muscle spasticity; and involuntary slow movements of the limbs (athetosis). About one-third of affected children learn to walk. It is caused by mutations in the SLC17A5 gene and is inherited in an autosomal recessive manner. Treatment is generally symptomatic and supportive."],"scope":"exact","source":"MONDO","upstream":"https://rarediseases.info.nih.gov/diseases/4754/salla-disease","url":"https://monarchinitiative.org/MONDO:0011449"},"ownColumnKeys":["population-a7e411db59480682eb71"],"publication":"published","relationships":[{"kind":"parent","label":"disorder of carbohydrate transmembrane transport and absorption","mondoId":"MONDO:0017706","slug":null},{"kind":"parent","label":"free sialic acid storage disease","mondoId":"MONDO:0019366","slug":"free-sialic-acid-storage-disease"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"multiple-identity-targets","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/free-sialic-acid-storage-disorder"},{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/4754"}],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"17159327a4b9abbd087a654ab00c56104661dfce21cd45487df790ac849815f0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"365af1a2ce4194b46d1a946f0fc77b315be56e0186eed2cea4ff42ba26d33d20","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002684","is_excluded":false,"label":"Thickened calvaria","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"385de33c23ea72889bc0388bf8328c31988a7de57b43ee31cb51b2d844dc6556","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"41b7eb0f152567c1681ef77ce0e7e49747f072e7c00bb72364d3d9a062a09760","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"4303c09d7ef57d030065e5ed902fa21041f4f2d287dd4b066b00f6aabf8e4189","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002540","is_excluded":false,"label":"Inability to walk","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"59f7e34e96c82d43f26169349b49184b8857bc58050e20ebd943ef79e5ba2290","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"86e9d5f297ee594df7f45baf174d037cd7677cb61bba268229c5ce004a90d83d","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001510","is_excluded":false,"label":"Growth delay","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"8b615393af23131f751a0873c8b45ece50dea4a8fa14aea6d0baf045ba5fcf39","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"93788962841d1313db9553fc51fe107348c02634fde482bdd5ebc58aee7b30e1","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001922","is_excluded":false,"label":"Vacuolated lymphocytes","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"9465ed937a06cef2d8f0d52ef53ffd8d1337636dab1c3a9bd9ba449793bf2532","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a1ae4e67d24e9a9fbb63cd01d8a92075ef6bacaacf5fbed8af8fd1699d0242f7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002305","is_excluded":false,"label":"Athetosis","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a4cc05008e1da088a62ea2f6983b07cdbd6bde3a7c5faa65ee8d42ada26679f3","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001290","is_excluded":false,"label":"Generalized hypotonia","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"b18c2685f9a9f3ae557be7545217dd4c8f0ce1bf010248374b903a933aee0deb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ba65364c82298a91287bb76ddeda9edd131bd34d632a24866f5c0ca7305dcfaf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"bec4cc46b3180f7e7ea2b27f947147b455ed1bb0fd5cb26071f078001f7b3294","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c5198ab12085969bbfc48144d62c77730a26d6e1d61ace4f0c2a96072388ffd9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001939","is_excluded":false,"label":"Abnormality of metabolism/homeostasis","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"d115f486f45d2b50c888e31dcc3befd9eb379ada3fc294dcf4da5c7bdd9f9ffe","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:604369","disease_name":"Salla disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000577","is_excluded":false,"label":"Exotropia","onset_id":null,"reference":"OMIM:604369","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011449\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>https://rarediseases.info.nih.gov/diseases/4754/salla-disease</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Salla disease is the mildest form of the free sialic acid storage disorders, which primarily affect the nervous system. Infants with Salla disease typically begin to experience poor muscle tone (hypotonia) during the first year of life,followed by slowly progressive neurological problems. Signs and symptoms include intellectual disability and developmental delay; seizures ; ataxia ; muscle spasticity; and involuntary slow movements of the limbs (athetosis). About one-third of affected children learn to walk. It is caused by mutations in the SLC17A5 gene and is inherited in an autosomal recessive manner. Treatment is generally symptomatic and supportive.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011449\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"salla-disease","sourceDocuments":[{"name":"MONDO: Salla disease","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011449"}],"sourceNote":"","synonyms":["Salla disease","SD","sialic acid storage disease"],"takeawayHtml":"","title":"Salla disease"},"schemaVersion":1}
